about
Porphyrins as theranostic agents from prehistoric to modern times.Lymphatic imaging: focus on imaging probes.Conformationally Strained trans-Cyclooctene (sTCO) Enables the Rapid Construction of (18)F-PET Probes via Tetrazine LigationIntraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticleProspective of ⁶⁸Ga-radiopharmaceutical development.Dynamic PET simulator via tomographic emission projection for kinetic modeling and parametric image studies.Molecular imaging and radiotherapy: theranostics for personalized patient managementProspective of 68Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation.
P2860
Q28716876-18A6F03B-0051-473D-8365-BA02E281F2F4Q35475925-A186DB9F-050F-496D-9A45-819DDDED3B6BQ36882982-0055E0AB-6355-49EF-801F-C6B16D9DB672Q36994123-8DA7A313-84EF-4A49-86C4-1B621409DAF9Q37435222-BE312E5B-64D8-456B-A8DE-BBD2763C8A5EQ39700078-FC84F050-A3DE-443C-8DDC-51C1E79F1FE0Q41850012-242F2036-0E4B-45E2-AF16-87483CAF3742Q54257268-9F219389-93FD-4673-9EB0-F55B61D38B22
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
How Does the Patient Benefit from Clinical PET?
@ast
How Does the Patient Benefit from Clinical PET?
@en
type
label
How Does the Patient Benefit from Clinical PET?
@ast
How Does the Patient Benefit from Clinical PET?
@en
prefLabel
How Does the Patient Benefit from Clinical PET?
@ast
How Does the Patient Benefit from Clinical PET?
@en
P2860
P356
P1433
P1476
How Does the Patient Benefit from Clinical PET?
@en
P2093
Jens Sörensen
P2860
P304
P356
10.7150/THNO.3794
P577
2012-05-04T00:00:00Z